2025. REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION. Global Journal of Public Health Medicine. 7, 1 (Jul. 2025), 208–215. DOI:https://doi.org/10.37557/gjphm.v7i1.336.